The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPMR.L Regulatory News (PMR)

  • There is currently no data for PMR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

27 Sep 2016 07:00

RNS Number : 8761K
Panmure Gordon & Co. plc
27 September 2016
 

27 September 2016

 

 

 

Panmure Gordon & Co. plc

 

 

Interim results

 

London, 27 September 2016 - Panmure Gordon & Co. plc ("Panmure Gordon" or "the Group"), a leading independent stockbroker and investment bank, today announces its results for the first half ended 30 June 2016.

 

 

Key points

 

· Growth of 14.0% in total net commission and fee income to £14.9m (H1 2015: £13.1m)

· Profit before non-recurring items and tax £1.7m (H1 2015: profit of £0.2m)

· Pre-tax profit of £0.3m (H1 2015: loss of £0.2m)

· Post-tax profit of £0.2m (H1 2015: loss of £0.2m)

· Earnings per share of 1.08p (H1 2015: loss per share of 1.09p)

· Strategic investment in PrimeXtend, a business focussed on the evolution of agency broker services Continued support and cooperation from Qinvest, including the granting of a £5m funding facility in February of which £3m has been drawn down

 

Patric Johnson, Chief Executive, commented:

 

I am pleased to report a positive start to the year particularly bearing in mind the significant volatility in the market leading up to the European Referendum. Business activity in July and August has continued to be encouraging including the first post-referendum technology AIM market IPO in August. However, continued market volatility following the result of the Referendum poses significant challenges for the medium term.

 

Despite the market volatility however, we executed 29 transactions including nine M&A deals and five IPOs which maintains our position within the top brokers in the AIM space. Together with the realignment of the business along sector lines, we have removed a significant level of annualised costs and we continue to drive efficiencies within our model. Critical to the positive momentum in our business are our relationships with our institutional clients and our ability to distribute quality transactions. We are pleased to report that Panmure Gordon sponsored IPO activity since January 2015 has returned a net gain of just over 30% for such clients.

 

We remain committed to the longer term strategic realignment of the business with additional investments to diversify our income and continuing to invest in quality people who remain at the heart of our business. We do however remain conservative in our outlook for the remainder of 2016."

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

 

 

Enquiries:

 

Panmure Gordon

Patric Johnson, Chief Executive

Philip Tansey, Chief Financial Officer 020 7886 2500

 

Buchanan (Financial PR)

Bobby Morse

Stephanie Watson 020 7466 5000

Grant Thornton UK LLP (Nominated Adviser)

Philip Secrett/Salmaan Khawaja/Jen Clarke 020 7383 5100

 

 

 

 

 

 

Chief Executive's Review

 

Significant changes made to Panmure Gordon's cost base and the reorganisation around sector teams are starting to bear fruit. The first half of the year witnessed some of the most significant political shocks of recent years during the run-up to, and then following, the June European Referendum vote. Market sentiment and volatility have been severely impacted, though the indications are that some level of stability is returning to the market. With this backdrop, I am therefore even more pleased to see a positive first half of the year. This positive start to the year is despite the significant charge for the restructuring in H1, including redundancy costs of £1.4m.

 

We have assisted clients raise over £600m across 29 transactions including four successful UK IPOs and one on AIM Italia. Corporate finance and related income rose by 34.4% to £10.1m (H1 2015: £7.5m) in what was a challenging, but busy, six months. Total net commission and fee income has increased by 14.0% in H1 2016 to £14.9m (H1 2015: £13.1m). Total commission and trading for H1 2016 for the core UK business also showed a net increase on a like-for-like basis, with a 5.3% increase in net commission and trading income at £5.1m (H1 2015: £4.8m) despite the trend in declining volumes across the main stock markets on a year-on-year basis continuing in 2016. Overall however, net commission and trading income has shown a net decrease of 9.1% to £5.2m (H1 2015: £5.7m) on account entirely of the closure of our Swiss office.

 

QInvest

Panmure Gordon continues to enjoy an excellent relationship with its major shareholder, Qinvest, and in March drew down £3m of the £5m financing facility that was made available to assist growth plans for the future whilst providing further liquidity for ongoing business.

 

PrimeXtend

In continuing our efforts to diversify our income whilst not altering the core DNA of our business and culture we were delighted to announce on 22 September that we exchanged contracts for an exciting strategic investment in a new company, PrimeXtend Limited. We will inject a maximum investment of £2m over a period of ten months, subject to the achievement of certain milestones, for an initial 49% shareholding. PrimeXtend will set up the necessary straight through processing infrastructure and, in close partnership with Panmure Gordon, develop new markets in agency broking of a variety of asset classes to a wide range of institutions that are currently suffering from a lack of liquidity and broker options in the market.

 

Switzerland

Panmure Gordon has operated in Switzerland since 2007 through a representative office in Nyon. Limited opportunities for growth coupled with the longer-term history of losses led to the decision to cease regulated activity in January and to close the office. The business was sold to a third party who committed to continuing the business with the same staff under their own regulatory licences and we wish them well for the future. The impact of the closure of the office on the results for H1 2016 is a cost of £0.2m.

 

Singapore

The Singapore office introduced a number of excellent clients that resulted in transactions executed in the London market. However, it was felt that a local presence with the attached costs would not be justified in the future and the decision was taken therefore to close the office and the local legal entity.

 

Outlook

 

We have recorded an encouraging start in the first six months of the year with the new sector based structure, designed to maximise the high standard of service to our clients, beginning to yield results. We have started to see the benefit from the operational efficiencies put in place and this will become more impactful as the year moves into the second half. We will continue to invest on a selective basis in both people and opportunities to further our client-centric business model, as well as seek other business prospects whilst remaining focussed on optimising the cost base within this evolving environment.

 

Markets are still digesting the full impact of the June European Referendum and as the eventual outcome becomes clearer so we should see further moves to a stabilising economy. We have begun the second half on a positive note with the first AIM market post-referendum technology IPO as well as a number of significant fund raises and advisory transactions already completed. Our pipeline of corporate transaction activity appears robust though, as ever, remains to be executed. We have a strong and supportive major shareholder in QInvest and a clear sector-focused team structure filled with excellent people that provide us with some reassurance when set against the continuing uncertainties of the second half. We remain conservative in our outlook for the remainder of the year.

 

Patric Johnson

Chief Executive

 

Condensed consolidated interim statement of profit or loss and other comprehensive income (unaudited)

 

For the half year to 30 June 2016

 

 

 

£'000

 

 

Notes

 

 

 

6 months

30 June

2016

6 months

30 June

2015

12 months

31 December

2015

 

 

Commission and trading income

5,697

6,321

11,687

 

Commission and trading expense

(533)

(641)

(1,180)

 

Net commission and trading income

5,164

5,680

10,507

 

 

Corporate finance and related income

10,122

7,534

12,788

 

Loss on corporate investments

(364)

(127)

(270)

 

 

Net commission and fee income

14,922

13,087

23,025

 

 

Administrative expenses1

(12,814)

(12,667)

(26,493)

 

Redundancy, restructuring and other non-recurring charges1

(1,387)

(376)

(1,730)

 

Operating profit/(loss) before share-based payments

721

44

(5,198)

 

 

Share-based payments1

(355)

(264)

(470)

 

Goodwill impairment1

-

-

(13,201)

 

 

Operating profit/(loss)

366

(220)

(18,869)

 

 

Financial income

-

-

1

 

Financial expense

(83)

(5)

(17)

 

 

Net financial expense

(83)

(5)

(16)

 

 

 

Profit/(loss) before tax

 

283

 

(225)

(18,885)

 

 

Taxation

3

(115)

55

2,210

 

 

 

Profit/(loss) for the period

 

168

 

(170)

(16,675)

 

 

 

Total comprehensive income/(loss)

168

(170)

(16,675)

 

 

Basic profit/(loss) per share

4

1.08p

(1.09)p

(107.3)p

 

Diluted profit/(loss) per share

4

1.00p

(1.09)p

(107.3)p

1 Administrative expenses which total £14.6m (6 months 30 June 2015: £13.3m, 12 months 31 December 2015: £41.9m) have been presented separately here owing to their individual nature and size

 

The following notes form part of these financial statements.

.

Condensed consolidated interim statement of financial position (unaudited)

 

At 30 June 2016

 

£'000

 

 

Notes

As at

30 June

2016

As at

30 June

2015

As at

31 December

2015

Assets

Goodwill and intangibles

1,769

13,201

2,012

Plant and equipment

1,565

1,922

1,913

Available for sale investments

100

100

100

Deferred tax asset

1,424

523

1,547

Other receivables

6

363

471

409

Total non-current assets

5,221

16,217

5,981

Securities held for trading

8

7,728

8,600

5,804

Trade and other receivables

6

50,160

41,402

20,239

Cash and cash equivalents

4,643

4,254

4,985

Total current assets

62,531

54,256

31,028

Current liabilities

Trade payables

7

(42,491)

(31,532)

(14,115)

Tax and social security

(512)

(562)

(601)

Corporation tax liabilities

(49)

(195)

-

Other payables

7

(3,636)

(2,465)

(4,126)

Held for trading liabilities

8

(1,077)

(1,922)

(1,595)

Total current liabilities

(47,765)

(36,676)

(20,437)

Net current assets

14,766

17,580

10,591

Financing facilities

(3,000)

-

-

Deferred tax liability

(304)

(1,109)

(338)

Total non-current liabilities

(3,304)

(1,109)

(338)

Net assets

16,683

32,688

16,234

Equity

Issued share capital

5

622

622

622

Merger reserve

21,810

21,810

21,810

Other reserve

(8,186)

(7,960)

(8,112)

Retained earnings

2,437

18,216

1,914

Total equity

16,683

32,688

16,234

 

 

The following notes form part of these financial statements.

Condensed consolidated interim statement of cash flows (unaudited)

 

 

 

 

£'000

6 months

30 June

2016

6 months

30 June

2015

12 months

31 December

2015

 

Cash flows from operating activities

Profit/(loss) after tax

168

(170)

(16,675)

 

Net financial expense

83

5

16

 

Depreciation and amortisation

433

217

421

 

Intangibles impairment and amortisation

-

-

13,404

 

Movement in securities held for trading

(2,442)

(3,446)

(976)

 

Decrease/(increase) in amounts owed by market counterparties

171

(780)

(449)

 

Increase in trade and other receivables

(1,250)

(3,123)

(119)

 

(Decrease)/increase in trade payables and provisions

(788)

(311)

1,686

 

IFRS 2 share-based payments and related charges

355

264

470

 

Income tax expense/(credit)

115

(55)

(2,210)

 

Net cash flow from operating activities

(3,155)

(7,399)

(4,432)

 

 

 

Cash flows from investing activities

 

Financial income received

-

-

1

 

Acquisition of plant and equipment

(57)

(95)

(288)

 

Acquisition of available for sale investments

-

(100)

(100)

 

Acquisition of intangible assets

28

-

(1,877)

 

Net cash from investing activities

(29)

(195)

(2,264)

 

 

Cash flows from financing activities

 

Purchase of own shares for EBT

(78)

(173)

(326)

 

Financial expense

(83)

(5)

(17)

 

Financing facility

3,000

-

-

 

Repayment of EBT loan

3

3

4

 

Dividend paid

-

(363)

(366)

 

Net cash from financing activities

2,842

(538)

(705)

 

 

Net decrease in cash and cash equivalents

(342)

(8,132)

(7,401)

 

Cash and cash equivalents at 1 January

4,985

12,386

12,386

 

Cash and cash equivalents at 30 June / 31 December

4,643

4,254

4,985

 

 

Condensed consolidated interim statement of changes in equity for the half year to 30 June 2016

 

£'000

Issued share capital

Merger reserve

Other reserve

Retained earnings

Total equity

At 1 January 2016

622

21,810

(8,112)

1,914

16,234

Total comprehensive income for the period

Profit for the period

-

-

-

168

168

Other items recorded directly in equity

 

Dividend payment

-

-

-

-

-

Share-based payments

-

-

-

355

355

Purchase of own shares for EBT

-

-

(78)

-

(78)

Decrease in shares held by EBT

-

-

4

-

4

At 30 June 2016

622

21,810

(8,186)

2,437

16,683

 

Condensed consolidated interim statement of changes in equity for the half year to 30 June 2015

 

£'000

Issuedsharecapital

Merger reserve

Other reserve

Retained earnings

Totalequity

At 1 January 2015

622

21,810

(7,790)

18,485

33,127

Total comprehensive income for the period

(Loss) for the period

-

-

-

(170)

(170)

Other items recorded directly in equity

Dividend payment

-

-

-

(363)

(363)

Share-based payments

-

-

-

264

264

Purchase of own shares for EBT

-

-

(173)

-

(173)

Decrease in shares held by EBT

-

-

3

-

3

At 30 June 2015

622

21,810

(7,960)

18,216

32,688

 

 

Consolidated statement of changes in equity for the year ended 31 December 2015

 

 

£'000

Issued share capital

Merger reserve

Other reserve

Retained earnings

Total

equity

 

At 1 January 2015

622

21,810

(7,790)

18,485

33,127

 

Total comprehensive income

for the period

 

(Loss) for the year

-

-

-

(16,675)

(16,675)

 

Other items recorded

directly in equity

 

 

Dividend payment

-

-

-

(366)

(366)

 

Share-based payments

-

-

-

470

470

 

Purchase of own shares for

EBT

-

-

(326)

-

(326)

 

Decrease in shares held by

EBT

-

-

4

-

4

 

At 31 December 2015

622

21,810

(8,112)

1,914

16,234

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 Legal status and basis of preparation

 

1.1 Legal status

 

Panmure Gordon & Co. plc (the "Company") is a company domiciled in the United Kingdom. The address of the Company's registered office is One New Change, London, EC4M 9AF. The consolidated interim financial statements of the Company for the 6 months ended 30 June 2016 relate to the Company and its subsidiaries (together referred to as the "Group").

 

1.2 Basis of preparation and statement of compliance with International Financial Reporting Standards

 

The interim consolidated financial statements of the Group have been prepared in accordance with IAS 34 Interim Financial Reporting as issued by the International Accounting Standards Board ('IASB') and as endorsed by the EU. They do not include all of the information required for full annual financial statements and should be read in conjunction with the Group's consolidated financial statements for the year ended 31 December 2015, which were prepared in accordance with International Financial Reporting Standards ('IFRSs') as issued by the IASB and as endorsed by the EU. EU-endorsed IFRSs may differ from IFRSs as issued by the IASB if, at any point in time, new or amended IFRSs have not been endorsed by the EU.

 

The accounting policies are consistent with those applied by the Group in its 2015 annual financial statements. During the period ended 30 June 2016, the Group adopted a number of amendments to standards and interpretations which did not have a significant effect on the consolidated financial statements of the Group.

 

The Directors note that the business was profitable during the period and loss making during the previous financial year and the Group had cash resources of £4.6m at 30 June 2016 (2015: £4.3m) and short term borrowings of £3m (2015: nil). The Directors believe that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing these interim results.

 

1.3 Comparative information

 

These interim consolidated financial statements include comparative information as required by IAS 34 and the AIM Rules for Companies.

 

The comparative figures for the financial year ended 31 December 2015 are not the Company's statutory accounts for that financial year. Those accounts have been reported on by the Company's auditors and delivered to the registrar of companies. The report of the auditors was (i) unqualified, (ii) did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

 

1.4 Use of estimates and assumptions

 

The preparation of financial statements requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from those estimates. Judgements made by management in the application of adopted IFRSs that have a significant effect on the financial statements and estimates with a significant risk of material adjustment are discussed in note 1.1 within the Report and Financial Statements 2015 The areas highlighted in the year-end financial statements include:

 

i) Goodwill and investment in subsidiaries

ii) Deferred tax

iii) Provisions

iv) Share-based payments

v) Intangible assets

 

 

 

2 Segmental analysis

 

The Group reports its operating segments according to how the Group's Chief Operating Decision Maker (CODM) allocates resources to each segment and assesses performance. In this respect the Group's CODM has been defined as the Group's CEO.

 

The geographical division is made between the UK and Swiss operations only. In the segmental table below, the results of the Swiss office appear in the 'Other' column. It was decided to cease regulated activity in January and to close the office. The impact of the closure of the office on the results for H1 2016 is a cost of £0.2m

 

 There are no major customers that regularly account for more than 10% of revenue.

 

Segmental analysis for the 6 months to 30 June 2016, the 6 months to 30 June 2015 and the 12 months to 31 December 2015, reconciled to the income statement

 

UK

Other

Total

6 months

30 Jun

2016

6 months

30 Jun

2015

12 months

31 Dec

2015

6 months

30 Jun

2016

6 months

30 Jun

2015

12 months

31 Dec

2015

6 months

30 Jun

2016

6 months

30 Jun

2015

12 months

31 Dec

2015

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Net commission and trading income

 

5,096

 

4,840

 

9,280

 

68

 

840

 

1,227

 

5,164

 

5,680

 

10,507

Corporate finance fee income

9,859

6,852

11,896

10

19

37

9,869

6,871

11,933

Loss on corporate investments

 

(364)

 

(127)

 

(270)

 

-

 

-

 

-

 

(364)

 

(127)

 

(270)

Wealth management and other income

 

253

 

663

 

855

 

-

 

-

 

-

 

253

 

663

 

855

Net loss on AFS investments

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

Foreign exchange loss

(3)

(15)

73

-

(2)

(2)

(3)

(17)

71

On-going administration costs

(12,533)

(11,884)

(25,252)

(278)

(766)

(1,312)

(12,811)

(12,650)

(26,564)

Goodwill impairment

-

-

(13,201)

-

-

-

-

-

 (13,201)

Segmental operating profit/(loss)

 

2,308

 

329

 

(16,619)

 

(200)

 

91

 

(50)

 

2,108

 

420

 

(16,669)

Redundancy and restructuring charges

 

(1,387)

 

(376)

 

(1,730)

 

-

 

-

 

-

 

(1,387)

 

(376)

 

(1,730)

Share-based payment charges

 

(355)

 

(264)

 

(470)

 

-

 

-

 

-

 

(355)

 

(264)

 

(470)

Operating profit/(loss)

566

(311)

(18,819)

(200)

91

(50)

366

(220)

(18,869)

 

Net financial expense

 

(83)

 

(5)

 

(16)

 

-

 

-

 

-

 

(83)

 

(5)

 

(16)

Profit/(loss) before tax

483

(316)

(18,835)

(200)

91

(50)

283

(225)

(18,885)

 

Income tax

 

(110)

 

72

 

2,234

 

(5)

 

(17)

 

(24)

 

(115)

 

55

 

2,210

Profit/(loss) for the period

373

(244)

(16,601)

(205)

74

(74)

168

(170)

(16,675)

 

Net assets

UK

Other1

Total

As at

30 Jun

2016

As at

30 Jun

2015

As at

31 Dec

2015

As at

30 Jun

2016

As at

30 Jun

2015

As at

31 Dec

2015

As at

30 Jun

2016

As at

30 Jun

2015

As at

31 Dec

2015

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Non-current assets (inc goodwill)

5,221

16,217

5,981

-

-

-

5,221

16,217

5,981

Current assets

62,531

54,256

31,028

-

-

-

62,531

54,256

31,028

Current liabilities

(47,765)

(36,676)

(20,437)

-

-

-

(47,765)

(36,676)

(20,437)

Non-current liabilities

(3,304)

(1,109)

(338)

-

-

-

(3,304)

(1,109)

(338)

Capital expenditure

(57)

(95)

(288)

-

-

-

(57)

(95)

(288)

1The Swiss business operated as a representative office of the UK business and therefore shared assets with the UK business

 

 

 

 

3 Taxation

 

The current tax charge for the period is different from the standard rate of corporation tax in the UK of 20.00% (2015: 20.25%).

 

Tax on profit on ordinary activities:

6 months

30 June

2016

6 months

30 June

2015

12 months

31 December

2015

£'000

£'000

£'000

Analysis of tax charge in period:

UK corporation tax at 20.25% (2014: 21.50%)

Prior year adjustments

-

-

2

Current year tax charge

-

-

-

Foreign tax adjustments

(9)

(20)

-

(9)

(20)

2

Deferred tax

Prior year adjustments to deferred tax credit

-

4

338

Current year deferred tax credit/(charge)

(106)

71

1,870

(106)

75

2,208

Tax (charge)/credit on profits on ordinary activities

(115)

55

2,210

 

Effective tax rate:

40.6%

(24.4)%

(11.7)%

 

Factors affecting tax (charge)/credit:

 

Profit/(loss) on ordinary activities before tax

283

(225)

(18,885)

Profit/(loss) on ordinary activities multiplied by rate of UK corporation tax at 20.00% (2015: 20.25%)

(57)

45

3,824

Effects of:

Expenses not deductible for tax purposes

10

(49)

(24)

Impairment of consolidated goodwill not deductible for tax purposes

-

-

(2,673)

purposes

Differences relating to share schemes

(71)

71

(105)

Foreign tax

(5)

(17)

(22)

Change in corporation tax rate

15

-

(216)

Deemed goodwill amortisation

-

53

-

Goodwill on consolidation

-

(53)

-

Impairment of consolidated goodwill write off on deferred tax

-

-

1,058

liability

Charles Stanley Securities intangible

(6)

-

-

Adjustment to tax charge in respect of previous periods

(1)

5

368

Total tax (charge)/credit on profits on ordinary activities

(115)

55

2,210

 

 

At 30 June 2016 the Group has recognised a deferred tax asset relating to UK losses carried forward.

 

 

4 Earnings per share

 

Earnings per share (EPS) are calculated on a net basis using the profit on ordinary activities after taxation divided by the weighted average number of shares detailed below.

 

Total Group

 

6 months

6 months

12 months

30 June

30 June

31 December

2016

2015

2015

Weighted average number of ordinary shares in issue

15,545,473

15,545,473

15,545,473

Fully diluted weighted average number of ordinary shares in issue

16,771,419

16,434,444

15,682,490

Basic profit /(loss) per share

1.08p

(1.09)p

(107.3)p

Diluted profit /(loss) per share

1.00p

(1.09)p

(107.3)p

 

 

5 Share capital and reserves

 

The Company issued no new shares during the six months to 30 June 2016.

 

As at 30 June 2016, the number of shares in issue was 15,545,473 ordinary shares at a par value of 4p (30 June 2015: 15,545,473 ordinary shares at a par value of 4p). The fully diluted number of ordinary shares was 16,771,419 (30 June 2015: 16,434,444).

 

The 'other reserve' includes the nominal value of share capital owned by the Panmure Gordon & Co. plc No. 2 Employee Benefit Trust (the "Trust") in respect of the 2005 Employee Share Option Plan and the cost of shares purchased in the market. At 30 June 2016 the Trust held 1,093,836 ordinary shares (December 2015: 1,272,354 ordinary shares).

 

 

6 Trade and other receivables

 

As at

As at

As at

 

30 June

30 June

31 December

2016

2015

2015

£'000

£'000

£'000

Non-current assets

Other receivables

363

471

409

Total

363

471

409

Current assets

Trade receivables

1,507

675

1,666

Stock borrow1

1,573

2,694

1,298

Market receivables

43,135

32,732

14,510

Other receivables

1,103

2,069

1,404

Prepayments and accrued income

2,842

3,232

1,361

Total

50,160

41,402

20,239

1 Stock borrow reflects collateral placed against the value of stock borrowed.

 

The level of market receivables at a period end is dependent on the level of agency and trading activity in the preceding days. Within non-current assets, other receivables represent loans made to employees under the Group's Matching Share Plan.

 

 

7 Trade and other payables

 

As at

As at

As at

30 June

30 June

31 December

2016

2015

2015

£'000

£'000

£'000

Market payables

(41,782)

(30,877)

(12,987)

Trade payables

(709)

(655)

(1,128)

Total trade payables

(42,491)

(31,532)

(14,115)

Other payables

(1,481)

(659)

(1,895)

Provisions, accruals and deferred income

(2,155)

(1,806)

(2,231)

Total other payables

(3,636)

(2,465)

(4,126)

 

 

 

The level of market payables at a period end is dependent on the level of agency and trading activity in the preceding days.

 

Litigation

 

In the normal course of business there may be various litigation claims and contingencies pending against the Group which, in the opinion of management, will be resolved with no material impact on the Group's financial position or results of operations.

 

 

 

8 Financial Instruments

The group measures fair values using the following fair value hierarchy that reflects the significance of the inputs used in making the measurements. The different levels have been defined as follows:

 

§ Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities

§ Level 2: inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices)

§ Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

The table below analyses financial instruments carried at fair value by valuation method.

 

Group

At 30 June 2016

At 30 June 2015

Level 1

Level 2

Level 3

Total

Level 1

Level 2

Level 3

Total

Available for sale assets

-

-

100

100

-

-

100

100

Assets held for trading

4,532

3,196

-

7,728

6,190

2,323

87

8,600

Liabilities held for trading

(627)

(450)

-

(1,077)

(1,628)

(294)

-

(1,922)

 

 

 

At 31 December 2015

Level 1

Level 2

Level 3

Total

Available for sale assets

-

-

100

100

Assets held for trading

3,216

2,584

4

5,804

Liabilities held for trading

(1,240)

(355)

-

(1,595)

 

 

There have been no transfers of assets between the levels noted above in the period under review.

 

 

9 Investment

 

On 22 September 2016 Panmure Gordon exchanged contracts to make an all-cash investment in a new company, PrimeXtend Limited, of up to a maximum of £2m over a period of ten months, subject to the satisfaction of certain performance milestones, for an initial 49% shareholding with the balance retained by Xtend Group Limited. PrimeXtend Limited will operate under Panmure Gordon's name.

 

 

10 General

 

The interim report was approved by the Board of Directors on 26 September 2016.

 

On account of the reducing level of complexity of the business and the increased simplicity of the associated accounting the Board considered it unnecessary to engage KPMG, auditors to the Group, to conduct a review of the financial statements in this half-yearly report for the six months ended 30 June 2016.

 

This report will be made available to the public, upon request, at the registered office of Panmure Gordon & Co. plc, One New Change, London EC4M 9AF or from the Company's website www.panmure.com.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR KQLFLQKFZBBL
Date   Source Headline
18th Jul 201712:18 pmRNSScheme of Arrangement Becomes Effective
18th Jul 20177:30 amRNSSuspension - Panmure Gordon & Co. plc
14th Jul 20174:50 pmRNSCourt Sanction of the Scheme of Arrangement
7th Jul 20171:15 pmRNSSettlement Agreement
30th Jun 20177:00 amRNSSecond Timetable Update
16th Jun 20179:53 amRNSForm 8.3 - PANMURE GORDON & CO PLC
14th Jun 20175:35 pmRNSTimetable Update
13th Jun 201712:15 pmRNSElections For Unlisted Share Alternative
8th Jun 201710:45 amRNSResult of AGM
2nd Jun 20174:25 pmRNSSubmission of Deeds of Adherence Extension
23rd May 20172:15 pmRNSDirectorate Change
9th May 20171:27 pmBUSNotice of AGM
28th Apr 201712:50 pmRNSResult of Court Meeting and General Meeting
12th Apr 20177:00 amRNSPublication and Posting of the Scheme Document
10th Apr 20179:00 amRNSRule 2.10(b) Northcote (IOM) Limited
4th Apr 20177:00 amRNSPreliminary Results 2016
31st Mar 20171:15 pmRNSForm 8.3 - Panmure Gordon & Co. plc
31st Mar 201711:49 amRNSForm 8.3 - Panmure Gordon & Co. Plc
31st Mar 201711:31 amRNSForm 8.3 - Panmure Gordon & Co Plc
31st Mar 20179:44 amPRNForm 8.3 - Panmure Gordon ord 4p
31st Mar 20179:25 amRNSForm 8.3 - Panmure Gordon & Co. plc
30th Mar 201712:05 pmRNSForm 8 (OPD) - Panmure Gordon & Co. plc
30th Mar 20179:25 amRNSForm 8.3 - Panmure Gordon & Co Plc
27th Mar 20174:55 pmRNSForm 8.3 - Panmure Gordon & Co. plc
24th Mar 20172:30 pmRNSNotice of Final Results
22nd Mar 20179:00 amRNSForm 8 (OPD) Ellsworthy Limited
17th Mar 20177:00 amRNSRecommended Acquisition
7th Feb 201712:20 pmBUSHolding(s) in Company
27th Jan 20171:06 pmBUSHolding(s) in Company
26th Jan 201710:35 amBUSHolding(s) in Company
16th Jan 20177:00 amRNSDirectorate Change
9th Jan 201712:30 pmBUSHolding(s) in Company
9th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmBUSHolding(s) in Company
7th Dec 201612:58 pmBUSHolding(s) in Company
8th Nov 201612:19 pmBUSHolding(s) in Company
20th Oct 201610:34 amBUSEBT Trading Plan
18th Oct 20169:25 amBUSDirectorate change
11th Oct 201612:32 pmBUSHolding(s) in Company
27th Sep 20167:00 amRNSInterim Results
22nd Sep 201610:49 amBUSContract
8th Sep 201611:56 amBUSHolding(s) in Company
8th Sep 201610:08 amBUSHolding(s) in Company
15th Aug 20169:54 amBUSDirectorate change
26th Jul 201610:01 amBUSDirectorate change
12th Jul 20162:30 pmBUSHolding(s) in Company
7th Jun 201610:25 amBUSHolding(s) in Company
18th May 201610:45 amRNSResult of AGM
18th May 20167:30 amRNSAGM Statement
13th May 20165:18 pmBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.